(0.15%) 5 188.71 points
(0.25%) 38 950 points
(-0.07%) 16 339 points
(-0.74%) $77.90
(0.96%) $2.22
(-0.08%) $2 329.40
(0.18%) $27.66
(2.50%) $989.05
(-0.02%) $0.928
(0.51%) $10.88
(0.07%) $0.796
(-0.16%) $91.20
Live Chart Being Loaded With Signals
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally...
Stats | |
---|---|
本日の出来高 | 884 249 |
平均出来高 | 547 017 |
時価総額 | 14.66B |
EPS | CNY0 ( 2024-04-28 ) |
次の収益日 | ( CNY0 ) 2024-05-29 |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 38.81 |
ATR14 | CNY0.0900 (0.09%) |
ボリューム 相関
Shanghai Haohai 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Shanghai Haohai 相関 - 通貨/商品
Shanghai Haohai 財務諸表
Annual | 2023 |
収益: | CNY2.63B |
総利益: | CNY1.85B (70.34 %) |
EPS: | CNY2.44 |
FY | 2023 |
収益: | CNY2.63B |
総利益: | CNY1.85B (70.34 %) |
EPS: | CNY2.44 |
FY | 2023 |
収益: | CNY0 |
総利益: | CNY0 (0.00 %) |
EPS: | CNY0 |
FY | 2022 |
収益: | CNY2.10B |
総利益: | CNY1.45B (68.79 %) |
EPS: | CNY1.040 |
Financial Reports:
No articles found.
Shanghai Haohai
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, injectors, scalpels, etc.; orthopedics products, such as sodium hyaluronate injection and medical chitosan; wound repair products, including recombinant human epidermal growth factor for the treatment of burn wound, residual wound, donor site posttraumatic wound, and fresh or old wound of chronic ulcer; anti-adhesion materials comprising medical sodium hyaluronate gel and medical chitosan; and hemostatic materials, such as collagen sponge and porcine fibrin sealants. The company also provides medical aesthetics products comprising Matrifill, a first-generation HA dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; and radio frequency devices and laser equipment. In addition, it is involved in research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; and investment and trading business. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。